Trial record 1 of 1 for:    Peanut Reactivity Reduced by Oral Tolerance in an anti-IgE Clinical
Previous Study | Return to List | Next Study

Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial (PRROTECT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Children's Hospital Boston
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
Stanford University
Ann & Robert H Lurie Children's Hospital of Chicago
Information provided by (Responsible Party):
Lynda Schneider, Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01781637
First received: January 30, 2013
Last updated: February 3, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)